Literature DB >> 31283989

Effect of multichannel transcranial direct current stimulation to reduce hypertonia in individuals with prolonged disorders of consciousness: A randomized controlled pilot study.

Aurore Thibaut1, Andrea Piarulli2, Géraldine Martens3, Camille Chatelle4, Steven Laureys5.   

Abstract

BACKGROUND: Spasticity management in severely brain-injured patients with disorders of consciousness (DOC) is a major challenge because it leads to complications and severe pain that can seriously affect quality of life.
OBJECTIVES: We aimed to determine the feasibility of a single session of transcranial direct current stimulations (tDCS) to reduce spasticity in chronic patients with DOC.
METHODS: We enrolled 14 patients in this double-blind, sham-controlled randomized crossover pilot study. Two cathodes were placed over the left and right primary motor cortex and 2 anodes over the left and right prefrontal cortex. Hypertonia of the upper limbs and level of consciousness were assessed by the Modified Ashworth Scale (MAS) and the Coma Recovery Scale-Revised (CRS-R). Resting state electroencephalography was also performed.
RESULTS: At the group level, spasticity was reduced in only finger flexors. Four responders (29%) showed reduced hypertonicity in at least 2 joints after active but not sham stimulation. We found no behavioural changes by the CRS-R total score. At the group level, connectivity values in beta2 were higher with active versus sham stimulation. Relative power in the theta band and connectivity in the beta band were higher for responders than non-responders after the active stimulation.
CONCLUSION: This pilot study highlights the potential benefit of using tDCS for reducing upper-limb hypertonia in patients with chronic DOC. Large-sample clinical trials are needed to optimize and validate the technique.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hypertonia; Minimally conscious state; Spasticity; Transcranial direct current stimulation; Upper motor neuron syndrome; Vegetative state

Mesh:

Year:  2019        PMID: 31283989     DOI: 10.1016/j.rehab.2019.05.009

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  6 in total

1.  tDCS-EEG for Predicting Outcome in Patients With Unresponsive Wakefulness Syndrome.

Authors:  Baohu Liu; Xu Zhang; Yuanyuan Li; Guoping Duan; Jun Hou; Jiayi Zhao; Tongtong Guo; Dongyu Wu
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

2.  Transcranial Pulsed-Current Stimulation versus Transcranial Direct Current Stimulation in Patients with Disorders of Consciousness: A Pilot, Sham-Controlled Cross-Over Double-Blind Study.

Authors:  Alice Barra; Martin Rosenfelder; Sepehr Mortaheb; Manon Carrière; Geraldine Martens; Yelena G Bodien; Leon Morales-Quezada; Andreas Bender; Steven Laureys; Aurore Thibaut; Felipe Fregni
Journal:  Brain Sci       Date:  2022-03-24

Review 3.  The Effect of Transcranial Direct Current Stimulation in Changing Resting-State Functional Connectivity in Patients With Neurological Disorders: A Systematic Review.

Authors:  Melody My Chan; Yvonne My Han
Journal:  J Cent Nerv Syst Dis       Date:  2020-12-15

4.  Changes of Spasticity across Time in Prolonged Disorders of Consciousness: A Retrospective Study.

Authors:  Benjamin Winters; Bruce Kuluris; Rita Pathmanaban; Hannelise Vanderwalt; Aurore Thibaut; Caroline Schnakers
Journal:  Brain Sci       Date:  2022-02-21

5.  Selective activation of central thalamic fiber pathway facilitates behavioral performance in healthy non-human primates.

Authors:  A P Janson; J L Baker; I Sani; K P Purpura; N D Schiff; C R Butson
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

6.  Effectiveness of transcranial direct current stimulation over dorsolateral prefrontal cortex in patients with prolonged disorders of consciousness: A systematic review and meta-analysis.

Authors:  Siwei Liu; Qiang Gao; Min Guan; Yi Chen; Shuhai Cheng; Lin Yang; Wei Meng; Chunyan Lu; Bingqian Li
Journal:  Front Neurol       Date:  2022-09-26       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.